Patent details
EP4225297 Title: COMBINATION THERAPY FOR TREATING CANCER
Basic Information
- Publication number:
- EP4225297
- PCT Application Number:
- EP2021077703
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP217944743
- PCT Publication Number:
- WO2022074124
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION THERAPY FOR TREATING CANCER
- French Title of Invention:
- POLYTHÉRAPIE POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 07/10/2021
- Grant date:
- 23/10/2024
- EP Publication Date:
- 16/08/2023
- PCT Publication Date:
- 14/04/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/10/2024
- EP B1 Publication Date:
- 23/10/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 07/10/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/10/2024
- Name:
- Astrazeneca AB
- Address:
- Forskargatan 18, 151 85 Södertälje, Sweden (SE)
Inventor
- Name:
- LEO, Elisabetta
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 202063089195 P
- Priority Date:
- 08/10/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/282; A61K 31/496; A61K 31/555; A61K 33/243; A61K 45/06; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 202443
- Publication date:
- 23/10/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 31/10/2025
- Annual Fee Number:
- 5
- Annual Fee Amount:
- 52 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|